Tumor
Conditions
Interventions
Index test:18F/68Ga/177Lu-labeled targeted molecular probes
Sponsors
The First Affiliated Hospital of Jinan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with treatment-naïve or recurrent solid tumors with highly suspicious imaging or histopathologically confirmed metastasis; 2. Age 18 years or older, male or female; 3. ECOG PS score of the Eastern Cooperative Oncology Group is 0-2 points; 4. Subjects voluntarily sign the informed consent form or their parents/children/legal guardians sign the informed consent form, and can complete the trial according to the requirements of the study protocol;
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Patients with severe liver and kidney dysfunction and cardiac insufficiency; 3. Patients with severe obesity, claustrophobia or other reasons that prevent PET scanning; 4. Patients who are not suitable for enrollment in the opinion of other investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standard uptake values, SUV;Sensitivity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Accuracy;Specificity; | — |
Countries
China
Contacts
Public ContactLu Wang; Jianfu Zhao
The First Affiliated Hospital of Jinan University
Outcome results
None listed